Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stock
Driven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal challenges, Emcure is projected...
Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stock
Driven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal challenges, Emcure is projected...
Gold prices continue to drop amid a strong dollar and US inflation concerns; check rates in your city
Gold prices have dropped by around 6% since Diwali, pressured by a stronger US dollar and rising inflation concerns. The price of 24-carat gold...
Investors not inclined to ‘sell India buy China’ but to ‘sell India buy USA’: Samir Arora
Samir Arora cautioned investors not to get overly excited by CLSA's increased allocation to India. He believes that investors were shifting to the US,...
Investors not inclined to ‘sell India buy China’ but to ‘sell India buy USA’: Samir Arora
Samir Arora cautioned investors not to get overly excited by CLSA's increased allocation to India. He believes that investors were shifting to the US,...